Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?

被引：7
作者：
Herr, Harry
Donat, Sherri Machele
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA
来源：
UROLOGY | 2016年 / 98卷
关键词：
CALMETTE-GUERIN; INFECTION; CANCER;
D O I：
10.1016/j.urology.2016.07.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 3
页数：3
相关论文
共 10 条
[1]   A PROSPECTIVE RANDOMIZED TRIAL OF MAINTENANCE VERSUS NONMAINTENANCE INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY OF SUPERFICIAL BLADDER-CANCER [J].
BADALAMENT, RA ;
HERR, HW ;
WONG, GY ;
GNECCO, C ;
PINSKY, CM ;
WHITMORE, WF ;
FAIR, WR ;
OETTGEN, HF .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) :441-449
[2]   Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer [J].
Biot, Claire ;
Rentsch, Cyrill A. ;
Gsponer, Joel R. ;
Birkhaeuser, Frederic D. ;
Jusforgues-Saklani, Helene ;
Lemaitre, Fabrice ;
Auriau, Charlotte ;
Bachmann, Alexander ;
Bousso, Philippe ;
Demangel, Caroline ;
Peduto, Lucie ;
Thalmann, George N. ;
Albert, Matthew L. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (137)
[3]   The Risk of Urinary Tract Infection after Flexible Cystoscopy in Patients with Bladder Tumor Who Did Not Receive Prophylactic Antibiotics [J].
Herr, Harry W. .
JOURNAL OF UROLOGY, 2015, 193 (02) :548-551
[4]   Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer [J].
Herr, Harry W. ;
Dalbagni, Guido ;
Donat, Sherri M. .
EUROPEAN UROLOGY, 2011, 60 (01) :32-36
[5]   Intravesical Bacille Calmette-Guerin in Patients With Asymptomatic Bacteriuria [J].
Herr, Harry W. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (14) :1413-1414
[6]   From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa [J].
Ingersoll, M. A. ;
Albert, M. L. .
MUCOSAL IMMUNOLOGY, 2013, 6 (06) :1041-1053
[7]   Trends in Stage-Specific Incidence Rates for Urothelial Carcinoma of the Bladder in the United States: 1988 to 2006 [J].
Nielsen, Matthew E. ;
Smith, Angela B. ;
Meyer, Anne-Marie ;
Kuo, Tzy-Mey ;
Tyree, Seth ;
Kim, William Y. ;
Milowsky, Matthew I. ;
Pruthi, Raj S. ;
Millikan, Robert C. .
CANCER, 2014, 120 (01) :86-95
[8]   Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials [J].
Sylvester, RJ ;
van der Meijden, APM ;
Oosterlinck, W ;
Witjes, JA ;
Bouffioux, C ;
Denis, L ;
Newling, DWW ;
Kurth, K .
EUROPEAN UROLOGY, 2006, 49 (03) :466-477
[9]   The microbiome of the urinary tract-a role beyond infection [J].
Whiteside, Samantha A. ;
Razvi, Hassan ;
Dave, Sumit ;
Reid, Gregor ;
Burton, Jeremy P. .
NATURE REVIEWS UROLOGY, 2015, 12 (02) :81-90
[10]   Antimicrobial peptides, normally sterile urinary innate immunity, and the tract [J].
Zasloff, Michael .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (11) :2810-2816
1